The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like This Drug Could be the Most Crucial in Regeneron's Massive Pipeline August 22, 2017 MorphoSys AG Reports Outcome Of Annual General Meeting 2017 May 16, 2017 <b>Harmony Biosciences</b> Gains U.S. Rights to Pitolisant, Raises $270 Million October 5, 2017